Do you want to skip to content? Skip to content
Contact Us Convatec.com Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
False /oidc-signin/en-us/ Contact Us Convatec.com Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

Non-Executive Directors - Appointment and Resignation

Convatec Group PLC (“Convatec” or “the Company”) is pleased to announce the appointment of Sharon O’Keefe as a Non-Executive Director of the Company with effect from 1 March 2022. Sharon will join Convatec’s Remuneration and Nomination committees on the same date.

The Company also announces that Rick Anderson, Non-Executive director, is stepping down from the Board with effect from 3 March 2022. Rick has made a significant and valuable contribution to Convatec since 2016 for which the Board is immensely grateful. Rick is also Chairman and MD of Revival Healthcare Capital, a role which has recently expanded, and this has led to his reluctant decision to step down from the Board of Convatec.

Sharon O’Keefe

From 2011 to 2020, Sharon was President and Chief Operating Officer of U Chicago Medicine, a US nationally ranked medical centre with a network of physicians and speciality clinics with 10,000 employees and operating revenue in excess of $2 billion.

Sharon has over 40 years of healthcare and executive experience, with particular focus on quality, efficiency and innovation to create high performance healthcare organisations.

Sharon is a non-executive director of Adtalem Global Education, a $1.1 billion global educational services company and of Vocera Communications, a $200 million healthcare technology company. She was previously a non-executive directors of Aviv REIT, a healthcare real estate investment trust that was acquired by Omega Healthcare Investors in 2015.

Sharon has an M.S. in Nursing Administration from the Loyola University of Chicago, and a B.S. in Nursing from the Northern Illinois University.

John McAdam, Chairman of Convatec, commented:

“I am delighted to welcome Sharon to our Board. She has extensive executive-level experience in medical centre environments with deep insight into patient care quality, engagement and innovation. Sharon brings to the Board very relevant international, medical and patient-focused experience. We look forward to Sharon’s contribution to our Board discussions.”

“The Board is sorry to lose Rick’s valuable contribution to the Board’s discussions and his deep insight into the medical device industry. The Board accepts that Rick is now having to devote more of his time to his role at Revival Healthcare and we wish Rick every success and happiness for the future.”

This announcement is made in accordance with Listing Rule 9.6.11R (1). No other information is required to be disclosed in accordance with Listing Rule 9.6.13.

Enquiries:

Analysts and Investors

Kate Postans, Vice President, Investor Relations +44(0)7826 447 807

ir@convatec.com

Media

Buchanan: Chris Lane +44(0)207 466 5000

Convatec Group PLC's LEI code is 213800LS272L4FIDOH92

About Convatec Group PLC

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about Convatec, please visit www.convatecgroup.com

Press Release

See all

17-Nov-22

Corporate

Capital Markets Event

Capital Markets Event

Read more

10-Nov-22

Corporate

Financial Performance

Convatec Group Plc Trading update for the ten months ended 31 October 2022

Read more

04-Aug-22

Corporate

Financial Performance

Interim Results for the six months ended 30 June 2022

Interim Results for the six months ended 30 June 2022

Read more

18-May-22

Corporate

New survey finds 87% of patients with long-term health conditions face stigma; nurses feel they lack time and resources to provide adequate support

Convatec makes 'forever caring' promise to patients and healthcare providers

Read more

12-May-22

Corporate

Financial Performance

AGM trading update for the four months ended 30 April 2022

AGM trading update for the four months ended 30 April 2022

Read more

09-May-22

Corporate

Continence Care

Convatec invests in BlueWind Medical to fund development of innovative neuromodulation technology

Convatec invests in BlueWind Medical to fund development of innovative neuromodulation technology

Read more

14-Mar-22

Corporate

Advanced Wound Care

Convatec Group completes acquisition of Triad Life Sciences Inc as it enters attractive wound biologics segment1

Convatec Group completes acquisition of Triad Life Sciences Inc as it enters attractive wound biologics segment1

Read more

08-Mar-22

Corporate

Financial Performance

Annual Results for the twelve months ended 31 December 2021

Annual Results for the twelve months ended 31 December 2021

Read more

28-Feb-22

Corporate

Our People

Non-Executive Directors - Appointment and Resignation

Non-Executive Directors - Appointment and Resignation

Read more

28-Jan-22

Corporate

Advanced Wound Care

Entry into the attractive wound biologics segment through the acquisition of Triad Life Sciences Inc

Entry into the attractive wound biologics segment through the acquisition of Triad Life Sciences Inc

Read more

27-Jan-22

Corporate

Our People

Board Committee Changes

Board Committee Changes

Read more